Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adoptively transferred TRAIL+ T cells suppress GVHD and augment antitumor activity
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 6, Pages 2654-2662
Publisher
American Society for Clinical Investigation
Online
2013-05-15
DOI
10.1172/jci66301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD8 T Cells Utilize TRAIL to Control Influenza Virus Infection
- (2014) E. L. Brincks et al. JOURNAL OF IMMUNOLOGY
- Targeting the Apo2L/TRAIL system for the therapy of autoimmune diseases and cancer
- (2012) Luis Martinez-Lostao et al. BIOCHEMICAL PHARMACOLOGY
- Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1+ leukemias
- (2012) E. Doubrovina et al. BLOOD
- Extrathymic development of murine T cells after bone marrow transplantation
- (2012) Amanda M. Holland et al. JOURNAL OF CLINICAL INVESTIGATION
- Multiple Redundant Effector Mechanisms of CD8+ T Cells Protect against Influenza Infection
- (2012) H. Hamada et al. JOURNAL OF IMMUNOLOGY
- Three-Dimensional Microscopy Characterization of Death Receptor 5 Expression by Over-Activated Human Primary CD4+ T Cells and Apoptosis
- (2012) Lucie Barblu et al. PLoS One
- Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL
- (2011) A. M. Hanash et al. BLOOD
- Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression
- (2011) M. C. Wolkers et al. BLOOD
- Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
- (2011) R. J. Brentjens et al. BLOOD
- TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells
- (2011) M. Iyori et al. JOURNAL OF IMMUNOLOGY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- Mixed T cell receptor dimers harbor potentially harmful neoreactivity
- (2010) M. M. van Loenen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease
- (2009) Il-Kang Na et al. JOURNAL OF CLINICAL INVESTIGATION
- Monitoring the Efficacy of Adoptively Transferred Prostate Cancer-Targeted Human T Lymphocytes with PET and Bioluminescence Imaging
- (2008) K. Dobrenkov et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
- (2008) Johannes L Zakrzewski et al. NATURE BIOTECHNOLOGY
- Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist
- (2008) A. J. Frew et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now